NICARDIPINE Drug Patent Profile

Which patents cover Nicardipine, and when can generic versions of Nicardipine launch?

Nicardipine is a drug marketed by Ani Pharms, Bionpharma, Epic Pharma Llc, Glenmark Pharms Ltd, Norvium Bioscience, Senores Pharms, Skg Pharma, Am Regent, Amneal, Chengdu Shuode, Eugia Pharma, Hikma, Hikma Intl Pharms, Micro Labs, Navinta Llc, Rk Pharma, Sun Pharm, Wockhardt, Inforlife, and Cipla. and is included in twenty-two NDAs.

The generic ingredient in NICARDIPINE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Nicardipine

A generic version of NICARDIPINE was approved as nicardipine hydrochloride by ANI PHARMS on October 28^th, 1996.

Summary for NICARDIPINE

US Patents:	0
Applicants:	20
NDAs:	22
Drug Prices:	Drug price information for NICARDIPINE
DailyMed Link:	NICARDIPINE at DailyMed

See drug prices for NICARDIPINE

US Patents and Regulatory Information for NICARDIPINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ani Pharms	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	CAPSULE;ORAL	074439-001	Dec 10, 1996		DISCN	No	No
Sun Pharm	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	INJECTABLE;INJECTION	078405-001	Nov 17, 2009		DISCN	No	No
Wockhardt	NICARDIPINE HYDROCHLORIDE	nicardipine hydrochloride	INJECTABLE;INJECTION	090671-001	Nov 17, 2009	AP	RX	No	No
Cipla	NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	215592-001	Sep 24, 2024	AP	RX	No	No
Cipla	NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE	nicardipine hydrochloride	INJECTABLE;INTRAVENOUS	215592-002	Sep 24, 2024	AP	RX	No	No